MTM(SH:688029) Sou Hu Cai Jing·2025-07-01 11:10Group 1 - The core viewpoint of the articles highlights the performance and valuation of Nanwei Medical, which closed at 69.64 yuan with a PE ratio of 22.92, marking a new low in 60 days and a total market capitalization of 13.082 billion yuan [1][2] - The average PE ratio for the medical device industry is 51.70, with a median of 37.36, positioning Nanwei Medical at the 49th rank within the industry [1][2] - As of the first quarter of 2025, 17 institutions hold shares in Nanwei Medical, including 11 funds, with a total holding of 10.64733 million shares valued at 7.017 billion yuan [1] Group 2 - Nanwei Medical specializes in the research, manufacturing, and sales of minimally invasive medical devices, with key products including biopsy, hemostasis, closure devices, EMR/ESD devices, dilation devices, ERCP devices, EUS/EBUS devices, ablation instruments, and disposable imaging systems [1] - The latest financial results for the first quarter of 2025 show that the company achieved a revenue of 699 million yuan, a year-on-year increase of 12.75%, and a net profit of 161 million yuan, also reflecting a year-on-year increase of 12.18%, with a gross profit margin of 65.69% [1]